Similar to their researches, we found TRIP inhibit TNFα-induced NF-κB pathway activation in RA, and we revealed the potential E3 ligase substrate target of TRIP in NF-κB signaling in our current study. This evidence concerns the gene NFKB1 and rheumatoid arthritis.